Scilight Press

Author Information

Received: 28 Mar 2025 | Revised: 03 Jun 2025 | Accepted: 12 Jun 2025 | Published: 17 Jun 2025

Abstract

Keywords

autoimmunity | neuropsychological functions | neuropsychological diagnostics

References 

• 1.
  Ganea, D.; Skarica, M. Immunoregulatory Neuropeptides. In Handbook of Psychoneuroimmunology; Kusnecov, A.W., Anisman, H., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2014; pp. 144–160.
• 2.
  Derecki, N.C.; Kipnis, J. Neural Functions of Hematopoietic-derived Cells. In Handbook of Psychoneuroimmunology; Kusnecov, A.W., Anisman, H., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2014; pp. 120–143.
• 3.
  Pereira de Sousa, L.; Ribiero-Gomes, F.L.; Farina de Almedia, R.; et al. The immune system challenge improves recognition memory and reverses malaria-induced cognitive impairment in mice. Sci. Rep. 2021, 11, 14857.
• 4.
  Quaedflieg, C.W.E.M.; Schneider, T.R.; Daume, J.; et al. Stress Impairs Intentional Memory Control Through Alerted Theta Oscilations in Lateral Parietal Cortex. J. Neurosci. 2020, 40, 7739–7748.
• 5.
  Kogan, S.; Ospina, L.H.; Mittal, V.A.; et al. The impact of Inflammation on neurocognition and risk of Psychosis: A Critical Review. Eur. Arch. Psychiatry Clin. Neurosci. 2020, 7, 793–802.
• 6.
  Kolliker-Frers, R.; Udovin LOtero-Losado, M.; Kobiec, T.; et al. Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease. Mediat. Inflamm. 2021, 2021, 9999146.
• 7.
  Alotiby, A. Immunology of stress: A Review Article. J. Clin. Med. 2024, 13, 6394.
• 8.
  Sechi, E.; Flanagan, E.P. Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front. Neurol. 2021, 12, 673339.
• 9.
  Galić, S. Neuropsihologijska Procjena, Testovi i Tehnike; Naklada Slap: Jastrebarsko, Croatia, 2002.
• 10.
  Schaefer, L.A.; Thakur, T.; Meager, M.R. Neuropsychological Assessment, StatPearls; NCBI Bookshelf: Bethesda, MD, USA, 2023.
• 11.
  Mesulam, M.M. From sensation to cognition. Brain 1998, 121, 1013–1052.
• 12.
  Lichtenberger, E.O.; Kaufman, A.S. WAIS-IV, Osnove Procjenjivanja; Naklada Slap: Jastrebarsko, Croatia, 2019.
• 13.
  Lezak, M.D. Neuropsychological Assessment; Oxford University Press: New York, NY, USA, 1995.
• 14.
  American Psychological Association. Dictionary of Psychology; American Psychological Association: Washington, DC, USA, 2025.
• 15.
  Bilać, S. Izvršne Funkcije i Teškoće u Ponašanju Kod Predškolske Djece s Perinatalnim Oštećenjm Mozga. Ph.D. Thesis, Filozofski Fakultet, Sveučilište u Zagrebu, Zagreb, Croatia, 2017.
• 16.
  Luria, A.R. The Working Brain; Basic Books: New York, NY, USA, 1973.
• 17.
  Miyake, A.; Friedman, N.P.; Emerson, M.J.; et al. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent variable analysis. Cogn. Psychol. 2000, 41, 49–100.
• 18.
  Rosczyk, H.A.; Sparkman, N.L.; Johnson, R.W. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp. Gerontol. 2008, 43, 840–846.
• 19.
  Pfau, M.L.; Russo, S.J. Neuroinflammation regulates cognitive impairment in socially defeated mice. Trends Neurosci. 2016, 39, 353–355.
• 20.
  Meszaros, Z.S.; Perl, A.; Faraone, S.V. Psychiatric Symptoms in Systemic Lupus Erythematosus: A Systematic Review. J. Clin. Psychiatry 2023, 7, 993–1001.
• 21.
  Churilov, L.P.; Sobolevskaia, P.A.; Stroev, Y.I. Thyroid Gland and brain: Enigma of Hashimoto’s encephalopathy. Best Pract. Res. Clin. Endocrinol. Metab. 2019, 33, 1–19.
• 22.
  Quinones, M.M.; Gallegos, A.M.; Vankee Lin, F.; et al. Dysregulation of Inflammation, Neurobiology, and Cognitive Function in PTSD: An Integrative Review, Cognitive. Affect. Behav. Neurosci. 2020, 20, 455–480.
• 23.
  Patel, V. The Challenge of Neuropsychiatric Systemic Lupus Erythematosus: From Symptoms to Therapeutic Strategies. Diagnostics 2024, 14, 1186.
• 24.
  Garrett, G.; Ambrose, N.; Davids, Z.; et al. Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE). Case Rep. Psychiatry 2017, 2017, 1–3.
• 25.
  Long Man, Y.L.; Sanna, G. Neuropsychiatric Manifestations of Antiphospholipid Syndrome–A Narrative Review. Brain Sci. 2022, 12, 91.
• 26.
  Lwin, M.N.; Serhal, L.; Holroyd, C.; et al. Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatol. Ther. 2020, 7, 457–471.
• 27.
  Kurina, L.M.; Goldcare, M.J.; Gill, L.E. Depression and anxiety in people with inflammatory bowel disease. J. Epidemiol. Community Health 2001, 55, 716–720.
• 28.
  Filipovic, B.R.; Filipovic, B.F. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J. Gastroenterol. 2014, 13, 3552–3563.
• 29.
  Kivity, S.; Agmon-Levin, N.; Zandman-Goddard, G.; et al. Neuropsychiatric lupus: A mosaic of clinical presentation, BMC Medicine. BioMed Cent. 2015, 13, 1–11.
• 30.
  30a. Samuels, M.H. Psychiatric and cognitive manifestations of hypothyroidism, Current Opinions in Endocrinology. Diabetes Obes. 2014, 5, 377–383.
• 31.
  McDowell, B.; Marr, C.; Holmes, C.; et al. Prevalence of cognitive impairment in patients with rheumatoid arthritis: A cross-sectional study. BMC Psychiatry 2022, 22, 520.
• 32.
  30b. Samuels, M.H.; Kolobova, I.; Smeraglio, A.; et al. The Effects of Levothyroxine Replacement or Suppressive Therapy on Health Status, Mood, and Cognition. J. Clin. Endocrinol. Metab. 2014, 3, 843–851.
• 33.
  Osterlind, S.J. Modern Measurement: Theory, Principles, and Applications of Mental Appraisal, 2nd ed.; Pearson Education: Boston, MA, USA, 2010.
• 34.
  Hays, R.D.; Hadron, D. Responsiveness to change: An aspect of Validity, not a Separate Dimension. Qual. Life Res. 1992, 1, 73–75.
• 35.
  Purisch, A.D.; Sbordone, R.J. The Luria-Nebraska Neuropsychological Battery. In Advances in Clinical Neuropsychology; Goldstein, G., Terter R.E., Eds.; Springer, Boston, MA, USA, 1986.
• 36.
  Golden, C.J.; Freshwater, S.M. Understanding Psychological Assessment; Dorfman, W.I., Hersen, M., Eds.; Kluwer Academic/Plenum Publishers: New York, NY, USA, 2001.
• 37.
  Mazur-Mosiewicz, A.; Dean, R.S. Halstead-Reitan Neuropsychological Test battery. In Encyclopedia of Child Behavior and Development; Goldstein, S., Naglieri, J.A., Eds.; Springer: Berlin/Heidelberg, Germany, 2011; pp. 727–731.
• 38.
  Stern, R.A.; White, T. NAB, Neuropsychological Assessment Battery: Administration, Scoring, and Interpretation Manual; Psychological Assessment Resources: Lutz, FL, USA, 2003.
• 39.
  Buczylowska, D.; Petermann, F.; Daseking, M. Executive functions and Intelligence from the CHC theory perspective: Investigating the correspondence between the WAIS-IV and NAB Executive Functions Module. J. Clin. Exp. Neuropsychol. 2020, 3, 240–250.
• 40.
  Roid, G.H.; Allen, E.A. Stanford-Binet Intelligence Scales (SB6 and Early SB5). In The SAGE Handbook of Clinical Neuropsychology: Clinical Neuropsychology Assessment and Diagnosis; SAGE: Newcastle upon Tyne, UK, 2024; pp. 299–316.
• 41.
  Wechsler, D.; Raiford, S.; Persnell, K.; Wechsler Adult Intelligence Scale, 5th ed.; Technical and Interpretive Manual; Pearson: San Antonio, TX, USA, 2024.
• 42.
  Meyers, J.E.; Meyers, K.R. Reyev Test Složenog Lika i Pokus s Prepoznavanjem–RCFT; Priručnik, Naklada Slap: Jastrebarsko, Croatia, 1998.
• 43.
  Brannigan, G.G.; Decker, S.L. Bender Vizualno-Motorički Test, Priručnik; Naklada Slap: Jastrebarsko, Croatia, 2005.
• 44.
  Ayearst, L.E. Continuous Auditory Test of Attention (CATA). In Encyclopedia of Clinical Neuropsychology; Kreutzer, J., DeLuca, J., Caplan, B., Eds.; Springer: Cham, Switzerland, 2018. https://doi.org/10.1007/978-3-319-56782-2_9054-1.
• 45.
  Achenbach, T.M.; Rescorla, L.A.; McConaughey, S.; et al. Achenbach System of Empirically Based Assessment. Am. Psychol. Assoc. 2003, 2, 406–432.
• 46.
  Grasso, M.; Lazzaro, G.; Demaria, F.; et al. The Strengths and Difficulties Questionnaire as a Valuable Screening Tool for Identifying Core Symptoms and Behavioural and Emotional Problems in Children with Neuropsychiatric Disorders. Int. J. Environ. Res. Public Health 2022, 19, 7731.
• 47.
  Roth, R.M.; Isquith, P.K.; Gioia, G.A. BRIEF·A: Behavior Rating Inventory of Executive Function·Adult Version; Psychological Assessment Resources: Odessa, FL, USA, 2005.
• 48.
  Hatheaway, S.R.; McKinley, J.C. Minnesota Multifazični inventar Ličnosti-2, Priručnik; Naklada Slap: Jastrebarsko, Croatia, 1999.
• 49.
  Morey, L.C. PAI, Inventar za Ispitivanje Ličnosti, Priručnik; Naklada Slap: Jastrebarsko, Croatia, 2014.
• 50.
  Bras, S.; Rojšek, J. Priručnik za Projektivnu Tehniku Mozaik PTM; Naklada Slap: Jatrebarsko, Croatia, 2005.
• 51.
  Beck, A.T.; Steer, R.S.; Brown, G.K. Beckov Inventar Depresije-II, Priručnik; Naklada Slap: Jastrebarsko, Croatia, 1998.
• 52.
  Spielberger, C.D. Priručnik za Upitnik Anksioznosti Kao Stanja i Osobine Ličnosti STAI; Naklada Slap: Jastrebarsko, Croatia, 2000.
• 53.
  Hamilton, M. The assessment of anxiety state by rating. Psychol. Psychother. 1959, 32, 50–55.
• 54.
  Yu, Y.; Wan, C.; Huebner, E.S.; et al. Psychometric properties of the symptom checklist 90 (SCL-90) for Chinese undergraduate students. J. Ment. Health 2019, 28, 213–219.
• 55.
  Weider, A.; Wolff, H.G.; Brodan, K.; et al. Priručnik za Cornell Index; Naklada Slap: Jastrebarsko, Croatia, 1997.
• 56.
  Smets, E.M.A.; Grassen, B.; Bonke, B.; et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995, 5, 315–325.
• 57.
  Hinz, A.; Benzing, C.; Bahler, E.; et al. Psychometric Properties of the Multidimensional Fatigue Inventory (MFI-20), Derived from Seven Samples. J. Pain Symptom Manag. 2020, 59, 717–724.
• 58.
  Lins, L.; Carvalho, M. SF-36 total score as a single measure of health-related quality of life: Scoping review. Sage Open Med. 2016, 4, 1–12.
• 59.
  LoMartire, R.; Ang, B.O.; Gerdle, B.; et al. Psychometric properties of Short Form-36 Health Survey, EuroQol 5-dimensions, and Hospital Anxiety and Depression Scale in patients with chronic pain. Pain 2020, 161, 83–95.
• 60.
  Melzack, R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975, 1, 277–299.
• 61.
  Main, C.J. Pain assessment in context: A state of the science review of the McGill pain questionnaire 40 years on. Pain 2016, 7, 1387–1399.
• 62.
  Cohen, S.R.; Russell, L.B.; Leis, A.; et al. More comprehensively measuring quality of life in life-threatening illness: The McGill Quality of Life Questionnaire–Expanded. BMC Palliat. Care 2019, 18, 1–11.
• 63.
  World Health Organization (WHO). WHOQOL User Manual; WHO: Geneva, Switzerland, 2025. Available online: https://www.who.int/toolkits/whoqol (accessed on 27 May 2025).